Technical Analysis for BZYR - Burzynski Research

Grade Last Price % Change Price Change
grade F 0.0141 7.63% 0.0010
BZYR closed up 7.63 percent on Monday, January 27, 2020, on 2.29 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BZYR trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction 7.63%
Narrow Range Bar Range Contraction 7.63%
BB Squeeze Started Range Contraction 7.63%
Wide Bands Range Expansion 7.63%
Older signals for BZYR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Burzynski Research Institute, Inc. is engaged in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids, which are known under the trade name Antineoplastons. Antineoplastons are found in the bodily fluids of humans and food. The Company is reviewing data of its Phase II clinical trials of Antineoplastons relating to the treatment of various cancers. All Phase II clinical trials are for the treatment of a range of cancers using only a combination of Antineoplastons A10 and AS2-1. Most of the trials involve the use of intravenous formulations of Antineoplastons, however, a few trials use oral formulations. The Company is also conducting laboratory research involving new generations of Antineoplastons, A10 and AS2-1.
Health Food Pharmaceutical Industry Drug Discovery Cancers Clinical Trial Pseudoscience Treatment Of Various Cancers Peptide Treatment Of A Range Of Cancers Health Fraud

Is BZYR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.09
52 Week Low 0.011
Average Volume 8,730
200-Day Moving Average 0.0311
50-Day Moving Average 0.0236
20-Day Moving Average 0.0162
10-Day Moving Average 0.0150
Average True Range 0.0039
ADX 5.5
+DI 46.3100
-DI 48.1550
Chandelier Exit (Long, 3 ATRs ) 0.0183
Chandelier Exit (Short, 3 ATRs ) 0.0247
Upper Bollinger Band 0.0223
Lower Bollinger Band 0.0101
Percent B (%b) 0.33
BandWidth 75.3086
MACD Line -0.0028
MACD Signal Line -0.0030
MACD Histogram 0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0141
Resistance 3 (R3) 0.0141 0.0141 0.0141
Resistance 2 (R2) 0.0141 0.0141 0.0141 0.0141
Resistance 1 (R1) 0.0141 0.0141 0.0141 0.0141 0.0141
Pivot Point 0.0141 0.0141 0.0141 0.0141 0.0141
Support 1 (S1) 0.0141 0.0141 0.0141 0.0141 0.0141
Support 2 (S2) 0.0141 0.0141 0.0141 0.0141
Support 3 (S3) 0.0141 0.0141 0.0141
Support 4 (S4) 0.0141